ADOC regimen

Revision as of 20:18, 27 February 2015 by Aparna Vuppala (talk | contribs)
Jump to navigation Jump to search

WikiDoc Resources for ADOC regimen

Articles

Most recent articles on ADOC regimen

Most cited articles on ADOC regimen

Review articles on ADOC regimen

Articles on ADOC regimen in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on ADOC regimen

Images of ADOC regimen

Photos of ADOC regimen

Podcasts & MP3s on ADOC regimen

Videos on ADOC regimen

Evidence Based Medicine

Cochrane Collaboration on ADOC regimen

Bandolier on ADOC regimen

TRIP on ADOC regimen

Clinical Trials

Ongoing Trials on ADOC regimen at Clinical Trials.gov

Trial results on ADOC regimen

Clinical Trials on ADOC regimen at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on ADOC regimen

NICE Guidance on ADOC regimen

NHS PRODIGY Guidance

FDA on ADOC regimen

CDC on ADOC regimen

Books

Books on ADOC regimen

News

ADOC regimen in the news

Be alerted to news on ADOC regimen

News trends on ADOC regimen

Commentary

Blogs on ADOC regimen

Definitions

Definitions of ADOC regimen

Patient Resources / Community

Patient resources on ADOC regimen

Discussion groups on ADOC regimen

Patient Handouts on ADOC regimen

Directions to Hospitals Treating ADOC regimen

Risk calculators and risk factors for ADOC regimen

Healthcare Provider Resources

Symptoms of ADOC regimen

Causes & Risk Factors for ADOC regimen

Diagnostic studies for ADOC regimen

Treatment of ADOC regimen

Continuing Medical Education (CME)

CME Programs on ADOC regimen

International

ADOC regimen en Espanol

ADOC regimen en Francais

Business

ADOC regimen in the Marketplace

Patents on ADOC regimen

Experimental / Informatics

List of terms related to ADOC regimen

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]

Overview

ADOC regimen refers to an immunochemotherapy regimen consisting of doxorubicin (Adriamycin), cisplatin (cis-Diamminedichloroplatinum), vincristine (Oncovin), cyclophosphamide used to treat invasive thymoma.[1]

Regimen

A – Adriamycin

D – Cisplatin (Cis-Diamminedichloroplatinum)

O – Vincristine (Oncovin)

C – Cyclophosphamide

Indications

References

  1. 1.0 1.1 Fornasiero A, Daniele O, Ghiotto C, Piazza M, Fiore-Donati L, Calabró F; et al. (1991). "Chemotherapy for invasive thymoma. A 13-year experience". Cancer. 68 (1): 30–3. PMID 2049749.